Fredun Pharmaceuticals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002605, "name": "Fredun Pharma", "stock_name": "Fredun Pharma", "full_name": "Fredun Pharmaceuticals Ltd", "name_url": "stocks-analysis/fredun-pharma", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "1,685.55", "chg": -8.2, "chgp": "-0.48%", "dir": -1, "prev_price": "1,693.75", "mcapval": "924.00 Cr", "mcap": "Micro Cap", "scripcode": 539730, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE194R01017", "curr_date": "Mar 30", "curr_time": "", "bse_nse_vol": "6.97 k", "exc_status": "Active", "traded_date": "Mar 30, 2026", "traded_date_str": "2026 03 30", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "MN", "url": "https://www.marketsmojo.com/mojopro/strategy/2", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Fredun Pharmaceuticals Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-ltd-is-rated-buy-3923779", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FredunPharmaceu_mojoScore_3923779.png", "date": "2026-03-30 10:10:31", "description": "Fredun Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 July 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 30 March 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Fredun Pharmaceuticals Gains 2.60%: 2 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-gains-260-2-key-factors-driving-the-week-3921739", "imagepath": "", "date": "2026-03-28 12:07:52", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>23 Mar:</strong> Bullish momentum confirmed with mojo grade upgrade to Buy</p>\n <p><strong>24 Mar:</strong> Valuation grade shifts from attractive to fair amid strong fundamentals</p>\n <p><strong>25 Mar:</strong> Stock rallies further, extending gains despite Sensex strength</p>\n <p><strong>27 Mar:</strong> Week closes with a mild correction, stock still up 2.60% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,650.85</div></div>\n <div class=\"stat-item\"><div class=\"..." }, { "title": "Fredun Pharmaceuticals Ltd: Valuation Shifts Signal Changing Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-valuation-shifts-signal-changing-price-attractiveness-3909094", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FredunPharmaceu_valuationdot_3909094.png", "date": "2026-03-24 08:01:54", "description": "Fredun Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. Despite this recalibration, the company continues to outperform the broader market, delivering impressive returns over multiple time horizons, signalling sustained investor interest amid evolving market dynamics." }, { "title": "Fredun Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-shows-bullish-momentum-amid-technical-upgrades-3906318", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FredunPharmaceu_technicaldot_3906318.png", "date": "2026-03-23 08:02:15", "description": "Fredun Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its Mojo Grade from Hold to Buy. The micro-cap pharmaceutical company’s shares have gained 2.61% today, closing at ₹1,662.00, reflecting renewed investor confidence amid improving technical trends and strong relative performance against the broader market." }, { "title": "Fredun Pharmaceuticals Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-ltd-is-rated-buy-3900057", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FredunPharmaceu_mojoScore_3900057.png", "date": "2026-03-19 10:10:49", "description": "Fredun Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook." }, { "title": "Fredun Pharmaceuticals Ltd: Technical Momentum Shifts Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-signals-3892763", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FredunPharmaceu_technicaldot_3892763.png", "date": "2026-03-16 08:02:42", "description": "Fredun Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a blend of bullish and bearish signals across key indicators. Despite a modest dip of 1.79% on 16 Mar 2026, the stock’s long-term performance remains robust, with a 1-year return of 143.07% significantly outpacing the Sensex’s 1.00% over the same period." }, { "title": "Fredun Pharmaceuticals Ltd Shows Strong Technical Momentum Amid Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-shows-strong-technical-momentum-amid-market-volatility-3884414", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FredunPharmaceu_technicaldot_3884414.png", "date": "2026-03-11 08:03:23", "description": "Fredun Pharmaceuticals Ltd has demonstrated a significant shift in price momentum, supported by a range of technical indicators signalling a bullish trend. With a notable 7.18% gain on the day and a recent upgrade from Hold to Buy by MarketsMOJO, the stock is attracting renewed investor interest amid a strong performance relative to the broader market." }, { "title": "Fredun Pharmaceuticals Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-ltd-is-rated-buy-3878603", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FredunPharmaceu_mojoScore_3878603.png", "date": "2026-03-08 10:10:38", "description": "Fredun Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 July 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 March 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Fredun Pharmaceuticals Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-ltd-is-rated-buy-3855096", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FredunPharmaceu_mojoScore_3855096.png", "date": "2026-02-25 10:11:10", "description": "Fredun Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." } ], "total": 230, "sid": "1002605", "stock_news_url": "https://www.marketsmojo.com/news/fredun-pharmaceuticals-1002605" }, "announcements": [ { "caption": "Disclosure Under Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015.", "datetime": "26-Mar-2026", "details": "Disclosure under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations 2015.", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "26-Mar-2026", "details": "Closure of Trading Window from 1st April 2026 till 48 hours after the end of the Board Meeting wherein Approval of Audited Financial Results for the quarter and year ended 31st March2026.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Conversion of Securities", "datetime": "25-Mar-2026", "details": "Allotment of 106668 Equity Shares to Promoter upon conversion of warrants into Equity Shares.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Fredun Pharmaceuticals Ltd has declared <strong>7%</strong> dividend, ex-date: 23 Sep 25", "dt": "2025-09-23", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

23 Mar: Bullish momentum confirmed with mojo grade upgrade to Buy

24 Mar: Valuation grade shifts from attractive to fair amid strong fundamentals

25 Mar: Stock rallies further, extending gains despite Sensex strength

27 Mar: Week closes with a mild correction, stock still up 2.60% for the week

Week Open

Rs.1,650.85

Read full news article

Fredun Pharmaceuticals Ltd: Valuation Shifts Signal Changing Price Attractiveness

2026-03-24 08:01:54

Fredun Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. Despite this recalibration, the company continues to outperform the broader market, delivering impressive returns over multiple time horizons, signalling sustained investor interest amid evolving market dynamics.

Read full news article

Fredun Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades

2026-03-23 08:02:15

Fredun Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its Mojo Grade from Hold to Buy. The micro-cap pharmaceutical company’s shares have gained 2.61% today, closing at ₹1,662.00, reflecting renewed investor confidence amid improving technical trends and strong relative performance against the broader market.

Read full news article

Fredun Pharmaceuticals Ltd is Rated Buy

2026-03-19 10:10:49

Fredun Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Fredun Pharmaceuticals Ltd: Technical Momentum Shifts Amid Mixed Signals

2026-03-16 08:02:42

Fredun Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a blend of bullish and bearish signals across key indicators. Despite a modest dip of 1.79% on 16 Mar 2026, the stock’s long-term performance remains robust, with a 1-year return of 143.07% significantly outpacing the Sensex’s 1.00% over the same period.

Read full news article

Fredun Pharmaceuticals Ltd Shows Strong Technical Momentum Amid Market Volatility

2026-03-11 08:03:23

Fredun Pharmaceuticals Ltd has demonstrated a significant shift in price momentum, supported by a range of technical indicators signalling a bullish trend. With a notable 7.18% gain on the day and a recent upgrade from Hold to Buy by MarketsMOJO, the stock is attracting renewed investor interest amid a strong performance relative to the broader market.

Read full news article

Fredun Pharmaceuticals Ltd is Rated Buy

2026-03-08 10:10:38

Fredun Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 July 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 March 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Fredun Pharmaceuticals Ltd is Rated Buy

2026-02-25 10:11:10

Fredun Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article